6-Chloro-9-(2,3,5-tri-O-benzoyl-2-C-methyl-beta-D-ribofuranosyl)-9H-purine structure
|
Common Name | 6-Chloro-9-(2,3,5-tri-O-benzoyl-2-C-methyl-beta-D-ribofuranosyl)-9H-purine | ||
---|---|---|---|---|
CAS Number | 205171-04-6 | Molecular Weight | 613.02 | |
Density | 1.41 | Boiling Point | 757.022ºC at 760 mmHg | |
Molecular Formula | C32H25ClN4O7 | Melting Point | N/A | |
MSDS | N/A | Flash Point | N/A |
Use of 6-Chloro-9-(2,3,5-tri-O-benzoyl-2-C-methyl-beta-D-ribofuranosyl)-9H-purine6-Chloro-9-(2,3,5-tri-O-benzoyl-2-C-methyl-beta-D-ribofuranosyl)-9H-purine dibenzoate is a purine nucleoside analog. Purine nucleoside analogs have broad antitumor activity targeting indolent lymphoid malignancies. Anticancer mechanisms in this process rely on inhibition of DNA synthesis, induction of apoptosis, etc[1]. |
Name | 6-Chloro-9-(2,3,5-tri-O-benzoyl-2-C-methyl-β-D-ribofuranosyl)-9H-purine |
---|---|
Synonym | More Synonyms |
Description | 6-Chloro-9-(2,3,5-tri-O-benzoyl-2-C-methyl-beta-D-ribofuranosyl)-9H-purine dibenzoate is a purine nucleoside analog. Purine nucleoside analogs have broad antitumor activity targeting indolent lymphoid malignancies. Anticancer mechanisms in this process rely on inhibition of DNA synthesis, induction of apoptosis, etc[1]. |
---|---|
Related Catalog | |
References |
Density | 1.41 |
---|---|
Boiling Point | 757.022ºC at 760 mmHg |
Molecular Formula | C32H25ClN4O7 |
Molecular Weight | 613.02 |
Exact Mass | 612.14100 |
PSA | 131.73000 |
LogP | 5.07540 |
Vapour Pressure | 0mmHg at 25°C |
Index of Refraction | 1.667 |
(2R,3R,4R,5R)-5-[(benzoyloxy)methyl]-2-(6-chloro-9H-purin-9-yl)-3-methyltetrahydrofuran-3,4-diyl dibenzoate |